Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple clinical vertebral fractures following denosumab discontinuation.

Literature DB >> 26694593

Multiple clinical vertebral fractures following denosumab discontinuation.

A D Anastasilakis¹, P Makras².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 26694593 DOI： 10.1007/s00198-015-3459-5

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

× No keyword cloud information.

2 in total

1. Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.

Authors: B Aubry-Rozier; E Gonzalez-Rodriguez; D Stoll; O Lamy
Journal: Osteoporos Int Date: 2015-10-28 Impact factor: 4.507

2. Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial.

Authors: Jacques P Brown; Christian Roux; Ove Törring; Pei-Ran Ho; Jens-Erik Beck Jensen; Nigel Gilchrist; Christopher Recknor; Matt Austin; Andrea Wang; Andreas Grauer; Rachel B Wagman
Journal: J Bone Miner Res Date: 2013-04 Impact factor: 6.741

2 in total

24 in total

Review 1. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.

Authors: Núria Guañabens; María Jesús Moro-Álvarez; Enrique Casado; Josep Blanch-Rubió; Carlos Gómez-Alonso; Guillermo Martínez Díaz-Guerra; Javier Del Pino-Montes; Carmen Valero Díaz de Lamadrid; Pilar Peris; Manuel Muñoz-Torres
Journal: Endocrine Date: 2019-04-08 Impact factor: 3.633

2. No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.

Authors: Nelson B Watts; Jane A Cauley; Rebecca D Jackson; Andrea Z LaCroix; Cora E Lewis; JoAnn E Manson; Joan M Neuner; Lawrence S Phillips; Marcia L Stefanick; Jean Wactawski-Wende; Carolyn Crandall
Journal: J Clin Endocrinol Metab Date: 2017-01-01 Impact factor: 5.958

3. Clinical vertebral fractures following denosumab discontinuation.

Authors: Stergios A Polyzos; Evangelos Terpos
Journal: Endocrine Date: 2016-07-08 Impact factor: 3.633

4. Cancel the denosumab holiday.

Authors: M R McClung
Journal: Osteoporos Int Date: 2016-03-01 Impact factor: 4.507

5. Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.

Authors: Joy N Tsai; Linda A Jiang; Hang Lee; Didier Hans; Benjamin Z Leder
Journal: J Clin Densitom Date: 2017-06-16 Impact factor: 2.617

Review 6. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.

Authors: Pojchong Chotiyarnwong; Eugene V McCloskey
Journal: Nat Rev Endocrinol Date: 2020-04-14 Impact factor: 43.330

7. Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates.

Authors: B Uebelhart; R Rizzoli; S L Ferrari
Journal: Osteoporos Int Date: 2017-05-24 Impact factor: 4.507